Hazel M. Aker, SVP, GC & Secretary at CADENCE PHARMACEUTICALS INC (CADX), sold 13,014 shares at $8.76 ($114K) on 2013-12-16, disclosed to the SEC on 2013-12-18.
Scheduled sale ($114k) by SVP, GC & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CADX | SELL | 2013-07-23 | $51K | — | Filing → |
| CADX | SELL | 2013-07-17 | $48K | — | Filing → |
| CADX | SELL | 2011-11-22 | $42K | — | Filing → |